- Technical Program
-
Breakfast / Registration
-
Morning Session
(Chairs: John Wang & Mike Biros)
Welcoming Remarks: Matthew Sills, President, SBS
Bringing the Human Genome into Three Dimensions
Tim Harris, President & CEO, Structural GenomiX
LabChip® Applications for Drug Discovery: Results from the
Amgen-Caliper Collaboration
Mike Johnson, Associate Scientist, Amgen, Inc.
Applications of Fluorescence Imaging Technology in Target Validation and
Drug Screening: A Comparison of Cellomics, FMAT, & FLIPR
Technologies
Meina Liang, Senior Scientist/Group Leader, Abgenix
-
Exhibit Viewing and Lunch Break
-
AfternoonSession
(Chairs: Richard Eglen & Alex Harris)
A Taste of Things to Come: Sweet and Bitter Perception
Charles Zuker, Professor, Investigator: Howard Hughes Med Inst UCSD
Small Molecule Anticoagulants from Phage Display Leads: Binding Assays for
Compound Evaluation
Maureen Beresini, Senior Scientist, Genentech, Inc.
The Cost and Reward for Moving to Higher Density Plate Format: Lessons
Learned from Migration to 384
Mike Doyle, Associate Director, Chiron Corp.
-
Break & Exhibit Viewing
Predictive Modeling for Early ADME Evaluation in Drug Discovery
George M. Grass, Lion Biosciences
Closing Remarks: Christine Giordano, Executive Director, SBS
- All Exhibiting Companies
|
|
|
